Categories: HealthcareNews

Venus Concept Celebrates Successful Completion of its NEXThetics Events Across North America

TORONTO, June 27, 2024 (GLOBE NEWSWIRE) — Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announces the successful completion of its NEXThetics events held across several major cities in North America. NEXThetics events bring together Venus Concept’s network of aesthetic leaders and practitioners and have seen a significant increase in popularity and attendance. Since our pilot events, the Company has hosted thousands of registrants, including its largest gathering to date in Houston, Texas on June 22, 2024.

“NEXThetics Houston was an outstanding event, centering on the core principles of the latest technology, networking, and delivering an unparalleled experience among attendees,” says Dr. Cheryl Haseeb of Pura Medical Aesthetics in Houston, Texas. “The attendees were highly engaged and eager to learn about the science behind this cutting-edge brand. They left energized and inspired to take their practice to the next level. It’s truly inspiring to witness the positive impact this event has had on our professional community.”

NEXThetics events are designed to showcase Venus Aesthetic Intelligence’s (“Venus AI”) Total Practice Performance philosophy and innovative technologies, including the recent successful launch of the Venus Versa Pro and strategies for maximizing profitability with Venus AI technologies. A broad spectrum of medical aesthetic professionals including dermatologists, plastic surgeons, hair restoration experts, practitioners, and spa owners have attended each event.

Venus AI’s direction focuses on integrating Aesthetic Intelligence into every aspect of its offerings, with the goal of enhancing total practice performance for all its partners. This holistic approach ensures that clients not only receive top-of-the-line technology but also the necessary support to achieve sustained success and profitability with dedicated teams and resources allocated to all Venus AI partners. These events also enhance brand recognition and provide attendees with opportunities to engage and learn from industry luminaries which provides a variety of perspectives, to help each participant understand what the latest trends are to better their practices or offerings and Venus Concept’s strength and ability to help in that journey.

Looking ahead to the remainder of 2024, NEXThetics Events will continue to expand across the United States, with upcoming events in Phoenix, Las Vegas, New York City, Atlanta, Dallas and Minneapolis.

“We are excited to continue driving innovation and education within the aesthetics and hair restoration industry,” says Ross Portaro, Executive Vice President & General Manager, Global Sales & Marketing of Venus Concept. “Join us at the future NEXThetics Events to elevate your practice and stay ahead of the curve.”

About Venus Concept

Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 12 direct markets. Venus Concept’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa PRO, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Venus Concept’s hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, Aperture Venture Partners, and Masters Special Situations.

CONTACT: Investor Relations Contact:
ICR Westwicke on behalf of Venus Concept:
Mike Piccinino, CFA
VenusConceptIR@westwicke.com

Staff

Recent Posts

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

55 minutes ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

57 minutes ago

Hallmark Adds Senior Executives to Enhance Customer Success and Strategic Partnerships

New leadership roles highlight Hallmark’s unique vendor-neutral approach to helping health systems build flexible, efficient,…

58 minutes ago

CARESYNTAX ANNOUNCES 2024 HIGHLIGHTS

 Company Celebrates Continued Worldwide Progress Toward Data-Driven Surgery SAN FRANCISCO and BERLIN, Dec. 23, 2024…

1 hour ago

Medit Launches a Mobile App, MEDIT M, to Revolutionize Digital Dental Workflows

SEOUL, South Korea, Dec. 23, 2024 /PRNewswire/ -- Medit has launched a mobile app, MEDIT…

1 hour ago

Nearly 50% of Young People Resolve to Quit Nicotine in 2025

EX Program by Truth Initiative Offers a Proven Path to Success WASHINGTON, Dec. 23, 2024…

1 hour ago